Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (23 quarters reported)
$34.4M in Q4 2020 → $108M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| KM Kestra Med Technologies Ltd | 53.8% | Unchanged | 2,282,519 | $58.1M |
| Whitehawk Therapeutics Inc | 20.6% | Added 135% | 4,861,314 | $22.3M |
| Alumis Inc | 6.6% | Trimmed 67% | 252,672 | $7.11M |
| Ceribell Inc | 6.2% | Trimmed 38% | 342,398 | $6.66M |
| Inventiva Sa | 5.3% | Unchanged | 1,500,000 | $5.67M |
| Promis Neurosciences Inc | 4.0% | Unchanged | 329,760 | $4.34M |
| Perspective Therapeutics Inc | 3.3% | Unchanged | 1,055,409 | $3.6M |
| American Bitcoin Corp. | 0.2% | Unchanged | 308,076 | $210K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Alumis Inc | Trimmed | −524,173 | −$14.8M | 6.6% |
| Whitehawk Therapeutics Inc | Added | +2,791,314 | +$12.8M | 20.6% |
| Ceribell Inc | Trimmed | −207,050 | −$4.03M | 6.2% |
quarter ended March 31, 2026 · filed May 18, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Perspective Therapeutics Inc | New | +1,055,409 | +$4.4M | 4.5% |
| Promis Neurosciences Inc | New | +329,760 | +$4.19M | 4.3% |
| American Bitcoin Corp. | New | +308,076 | +$285K | 0.3% |
| Alumis Inc | Trimmed | −12,773 | −$281K | 17.6% |
quarter ended December 31, 2025 · filed February 18, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Ceribell Inc | Trimmed | −803,718 | −$17.6M | 13.1% |
| Inventiva Sa | New | +1,500,000 | +$6.98M | 7.6% |
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cargo Therapeutics Inc | Exited | −912,000 | −$3.76M | — |
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cg Oncology Inc | Exited | −163,456 | −$4M | — |
| Ceribell Inc | Added | +130,964 | +$2.45M | 34.6% |
| Castle Biosciences Inc | Exited | −22,503 | −$451K | — |
| Sagimet Biosciences Inc | Exited | −57,190 | −$186K | — |
| Pyxis Oncology Inc | Exited | −69,303 | −$67.9K | — |
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| KM Kestra Med Technologies Ltd | New | +2,282,519 | +$56.9M | 58.5% |
| Whitehawk Therapeutics Inc | New | +2,070,000 | +$3.68M | 3.8% |
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Ceribell Inc | New | +1,222,202 | +$31.6M | 59.4% |
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cg Oncology Inc | Trimmed | −1,414,888 | −$53.4M | 19.0% |
| Castle Biosciences Inc | Trimmed | −14,244 | −$406K | 2.0% |
Loading...
